ARCHIVES

Funding Opportunities: NIAID seeks New Investigator, Risky Research Proposals

This article is from The Cancer Letter archive.

Vol. 23 No. 12 | March 28, 1997

Download PDF Visit The Full Archive

Related Articles

FDA to refer false statements by regulated companies to SEC.

February 27, 2004

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

Impetus to Proceed with a March Came From Talk Show

October 31, 1997

In Brief: SSO Plan Session On Grantmanship; Meeting On Free Standing Cancer Centers Is Postponed

May 2, 1986

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

March 21, 2003

Varmus: NCI Faces “Budgetary Disaster;” Flat Funds, Cuts Loom For Most Programs

January 14, 2011